Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Intestinal Obstruction × lanreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 5 Carcinoid Tumor 2 Serotonin Syndrome 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neuroendocrine Tumors in Lung 1 Intestinal Obstruction 1 Gastro-enteropancreatic neuroendocrine tumor 1 Flushing 1 Endocrine Tumors 1 Diarrhea 1 Carcinoma 1 Adenoma, Islet Cell 1

Interventions

lanreotide 1 Octreotide 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00216372 2020-11-05

Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis

Ipsen

Phase 3 Completed

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡